Northern Trust Corp Collegium Pharmaceutical, Inc Transaction History

Northern Trust Corp

  • $600 Billion
  • Q3 2024

A detailed history of Northern Trust Corp transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Northern Trust Corp holds 364,667 shares of COLL stock, worth $10.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
364,667
Previous 369,551 1.32%
Holding current value
$10.8 Million
Previous $11.9 Million 18.41%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$31.4 - $39.07 $153,357 - $190,817
-4,884 Reduced 1.32%
364,667 $14.1 Million
Q2 2024

Aug 14, 2024
SELL
$31.36 - $39.99 $454,343 - $579,375
-14,488 Reduced 3.77%
369,551 $11.9 Million
Q1 2024

May 14, 2024
SELL
$31.23 - $40.91 $525,538 - $688,433
-16,828 Reduced 4.2%
384,039 $14.9 Million
Q4 2023

Feb 13, 2024
SELL
$21.16 - $30.8 $66,717 - $97,112
-3,153 Reduced 0.78%
400,867 $12.3 Million
Q3 2023

Nov 13, 2023
SELL
$21.23 - $24.28 $51,716 - $59,146
-2,436 Reduced 0.6%
404,020 $9.03 Million
Q2 2023

Aug 11, 2023
BUY
$21.06 - $24.0 $383,292 - $436,800
18,200 Added 4.69%
406,456 $8.73 Million
Q1 2023

May 15, 2023
BUY
$23.0 - $29.88 $70,495 - $91,582
3,065 Added 0.8%
388,256 $9.31 Million
Q4 2022

Feb 13, 2023
SELL
$16.14 - $23.55 $20,400 - $29,767
-1,264 Reduced 0.33%
385,191 $8.94 Million
Q3 2022

Nov 14, 2022
BUY
$15.46 - $20.1 $62,659 - $81,465
4,053 Added 1.06%
386,455 $6.19 Million
Q2 2022

Aug 12, 2022
SELL
$14.22 - $20.88 $143,721 - $211,034
-10,107 Reduced 2.57%
382,402 $6.78 Million
Q1 2022

May 13, 2022
SELL
$17.2 - $22.5 $252,908 - $330,840
-14,704 Reduced 3.61%
392,509 $7.99 Million
Q4 2021

Feb 08, 2022
SELL
$17.5 - $21.35 $440,510 - $537,422
-25,172 Reduced 5.82%
407,213 $7.61 Million
Q3 2021

Nov 15, 2021
BUY
$17.75 - $25.39 $408 - $583
23 Added 0.01%
432,385 $8.54 Million
Q2 2021

Aug 13, 2021
SELL
$21.74 - $25.28 $131,722 - $153,171
-6,059 Reduced 1.38%
432,362 $10.2 Million
Q1 2021

May 12, 2021
SELL
$19.25 - $26.1 $356,741 - $483,685
-18,532 Reduced 4.06%
438,421 $10.4 Million
Q4 2020

Feb 11, 2021
SELL
$17.83 - $22.29 $356,207 - $445,309
-19,978 Reduced 4.19%
456,953 $9.15 Million
Q3 2020

Nov 16, 2020
SELL
$15.78 - $20.82 $276,465 - $364,766
-17,520 Reduced 3.54%
476,931 $9.93 Million
Q2 2020

Aug 14, 2020
BUY
$15.49 - $23.51 $1.07 Million - $1.63 Million
69,163 Added 16.26%
494,451 $8.65 Million
Q1 2020

May 14, 2020
BUY
$13.89 - $25.45 $115,439 - $211,514
8,311 Added 1.99%
425,288 $6.95 Million
Q4 2019

Feb 14, 2020
SELL
$10.7 - $22.24 $709,848 - $1.48 Million
-66,341 Reduced 13.73%
416,977 $8.58 Million
Q3 2019

Nov 13, 2019
BUY
$10.16 - $13.28 $974,120 - $1.27 Million
95,878 Added 24.75%
483,318 $5.55 Million
Q2 2019

Aug 13, 2019
BUY
$10.62 - $16.59 $44,614 - $69,694
4,201 Added 1.1%
387,440 $5.1 Million
Q1 2019

May 13, 2019
SELL
$13.58 - $18.72 $679 - $936
-50 Reduced 0.01%
383,239 $5.8 Million
Q4 2018

Feb 12, 2019
SELL
$14.78 - $19.68 $1.23 Million - $1.63 Million
-82,890 Reduced 17.78%
383,289 $6.58 Million
Q3 2018

Nov 14, 2018
SELL
$14.16 - $24.3 $854,131 - $1.47 Million
-60,320 Reduced 11.46%
466,179 $6.87 Million
Q2 2018

Sep 18, 2018
SELL
$21.79 - $28.29 $42,359 - $54,995
-1,944 Reduced 0.37%
526,499 $12.6 Million
Q2 2018

Aug 14, 2018
BUY
$21.79 - $28.29 $5.09 Million - $6.6 Million
233,407 Added 79.11%
528,443 $12.6 Million
Q1 2018

May 09, 2018
BUY
$18.15 - $29.21 $137,086 - $220,623
7,553 Added 2.63%
295,036 $7.54 Million
Q4 2017

Feb 14, 2018
BUY
$9.3 - $19.14 $120,667 - $248,341
12,975 Added 4.73%
287,483 $5.31 Million
Q3 2017

Nov 13, 2017
BUY
$9.15 - $11.97 $2.51 Million - $3.29 Million
274,508
274,508 $2.88 Million

Others Institutions Holding COLL

# of Institutions
255
Shares Held
38.6M
Call Options Held
100K
Put Options Held
21.1K
View Full List

About COLLEGIUM PHARMACEUTICAL, INC

COLL Quotes by TradingView
  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $1.01B
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email